Skip to main content
Have a personal or library account? Click to login
Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry Cover

Efficacy and Safety of Pharmacoinvasive Strategy Compared to Primary Percutaneous Coronary Intervention in the Management of ST-Segment Elevation Myocardial Infarction: A Prospective Country-Wide Registry

Open Access
|Feb 2020

References

  1. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med. 2011; 124(1): 4047. DOI: 10.1016/j.amjmed.2010.07.023
  2. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362(23): 21552165. DOI: 10.1056/NEJMoa0908610
  3. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119177. DOI: 10.1093/eurheartj/ehx393
  4. Zubaid M, Rashed WA, Almahmeed W, et al. Management and outcomes of Middle Eastern patients admitted with acute coronary syndromes in the Gulf Registry of Acute Coronary Events (Gulf RACE). Acta Cardiol. 2009; 64(4): 439446. DOI: 10.2143/AC.64.4.2041607
  5. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2013; 82(1): E127. DOI: 10.1002/ccd.24776
  6. Pinto DS, Frederick PD, Chakrabarti AK, et al. Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase. Circulation. 2011; 124(23): 25122521. DOI: 10.1161/CIRCULATIONAHA.111.018549
  7. Huber K, Goldstein P, Danchin N, et al. Enhancing the efficacy of delivering reperfusion therapy: A European and North American experience with ST-segment elevation myocardial infarction networks. Am Heart J. 2013; 165(2): 123132. DOI: 10.1016/j.ahj.2012.10.032
  8. Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013; 368(15): 13791387. DOI: 10.1056/NEJMoa1301092
  9. Pinto DS, Kirtane AJ, Nallamothu BK, et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: Implications when selecting a reperfusion strategy. Circulation. 2006; 114(19): 20192025. DOI: 10.1161/CIRCULATIONAHA.106.638353
  10. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Ann Intern Med. 2007; 147(8): 573577. DOI: 10.7326/0003-4819-147-8-200710160-00010
  11. Statistical Reports. http://stat.paci.gov.kw/englishreports/. Accessed May 2, 2019.
  12. Cannon CP, Brindis RG, Chaitman BR, et al. 2013 ACCF/AHA key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes and coronary artery disease: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Acute Coronary Syndromes and Coronary Artery Disease Clinical Data Standards). Crit Pathw Cardiol. 2013; 12(2): 65105. DOI: 10.1097/HPC.0b013e3182846e16
  13. Hatano S. Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976; 54(5): 541553.
  14. Hicks KA, Stockbridge NL, Targum SL, Temple RJ. Bleeding Academic Research Consortium consensus report: the Food and Drug Administration perspective. Circulation. 2011; 123(23): 26642665. DOI: 10.1161/CIRCULATIONAHA.111.032433
  15. Vora AN, Holmes DN, Rokos I, et al. Fibrinolysis use among patients requiring interhospital transfer for ST-segment elevation myocardial infarction care: A report from the US National Cardiovascular Data Registry. JAMA Intern Med. 2015; 175(2): 207215. DOI: 10.1001/jamainternmed.2014.6573
  16. Larson DM, McKavanagh P, Henry TD, Cantor WJ. Reperfusion options for ST elevation myocardial infarction patients with expected delays to percutaneous coronary intervention. Interv Cardiol Clin. 2016; 5(4): 439450. DOI: 10.1016/j.iccl.2016.06.004
  17. Sinnaeve PR, Armstrong PW, Gershlick AH, et al. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up. Circulation. 2014; 130(14): 11391145. DOI: 10.1161/CIRCULATIONAHA.114.009570
  18. Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): Randomised trial. Lancet. 2006; 367(9510): 569578. DOI: 10.1016/S0140-6736(06)68147-6
  19. Larson DM, Duval S, Sharkey SW, et al. Safety and efficacy of a pharmaco-invasive reperfusion strategy in rural ST-elevation myocardial infarction patients with expected delays due to long-distance transfers. Eur Heart J. 2012; 33(10): 12321240. DOI: 10.1093/eurheartj/ehr403
  20. Rashid MK, Guron N, Bernick J, et al. Safety and efficacy of a pharmacoinvasive strategy in ST-segment elevation myocardial infarction: A patient population study comparing a pharmacoinvasive strategy with a primary percutaneous coronary intervention strategy within a regional system. JACC Cardiovasc Interv. 2016; 9(19): 20142020. DOI: 10.1016/j.jcin.2016.07.004
  21. Sim DS, Jeong MH, Ahn Y, et al. Pharmacoinvasive strategy versus primary percutaneous coronary intervention in patients with ST-Segment-elevation myocardial infarction: A propensity score-matched analysis. Circ Cardiovasc Interv. 2016; 9(9). DOI: 10.1161/CIRCINTERVENTIONS.115.003508
  22. Belle L, Cayla G, Cottin Y, et al. French registry on acute ST-elevation and non-ST-elevation myocardial infarction 2015 (FAST-MI 2015). Design and baseline data. Arch Cardiovasc Dis. 2017; 110(6–7): 366378. DOI: 10.1016/j.acvd.2017.05.001
  23. AlHabib KF, Alfaleh H, Hersi A, Kashour T. Use of emergency medical services in the second gulf registry of acute coronary events. 2014. DOI: 10.1177/0003319713502846
  24. AlHabib KF, Sulaiman K, Al Suwaidi J, et al. Patient and system-related delays of emergency medical services use in acute st-elevation myocardial infarction: Results from the Third Gulf Registry of Acute Coronary Events (Gulf RACE-3Ps). PLoS One. 2016; 11(1): e0147385. DOI: 10.1371/journal.pone.0147385
DOI: https://doi.org/10.5334/aogh.2632 | Journal eISSN: 2214-9996
Language: English
Published on: Feb 5, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2020 Mohammad Zubaid, Haitham Khraishah, Barrak Alahmad, Wafa Rashed, Mustafa Ridha, Fahad Alenezi, Mohamad Aljarralah, Khalid Al-Marri, Mohammad Almutairi, Khalid Althalji, Abdulhamied Alfaddagh, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.